News & events Upcoming events Medlab Middle East 2020 Feb 3, 2020 - Feb 6, 2020 Dubai , United Arab Emirates More info and meet us there AISF Pre-Meeting & AISF Annual Meeting Feb 26, 2020 - Feb 28, 2020 Rome , Italy More info and meet us there 11th India Live 2020 Feb 28, 2020 - Mar 1, 2020 New Delhi , India More info and meet us there See all upcoming events Latest news Fujirebio launches INNO-LiPA® CFTRiage, allowing easy and efficient detection of CFTR mutations Jan 9, 2020 Fujirebio Europe announces the availability of its new INNO-LiPA CFTRiage approach for the detection of cystic fibrosis (CF) mutations. The... Read more Fujirebio Europe N.V. signs distribution agreement and extends its molecular product portfolio with the Atila Biosystems, Inc. product lines Nov 19, 2019 Fujirebio Europe N.V. announces to have signed a European, exclusive agreement with Atila Biosystems, Inc. for the distribution of the... Read more INNO-LiPA® HPV Genotyping Extra II now CE marked for use on self-collected first-void urine samples Sep 16, 2019 Fujirebio Europe announced today that its genotyping assay for Human Papilloma Virus (HPV), INNO-LiPA HPV Genotyping Extra II received a CE... Read more Fujirebio launches the automated Lumipulse® G AMH assay for accurate assessment of ovarian reserve Apr 26, 2019 Fujirebio Europe announces the release of the Lumipulse G AMH assay for automated quantitative measurement of anti-Müllerian hormone in... Read more Fujirebio expands its INNO-LiPA® CFTR assay portfolio with the launch of INNO-LiPA CFTR Extra Mar 18, 2019 Fujirebio Europe announces the release of the new INNO-LiPA® CFTR Extra assay for the detection of 18 new disease-causing cystic fibrosis... Read more Fujirebio Europe announces the availability of the Lumipulse® G pTau 181 and β-Amyloid 1-40 assays extending its offer of fully automated assays as an aid in the early diagnosis of Alzheimer’s disease Nov 27, 2018 Fujirebio Europe today announced the availability of the Lumipulse G pTau 181 and β-Amyloid 1-40 assays for its fully automated LUMIPULSE G... Read more Load More
Medlab Middle East 2020 Feb 3, 2020 - Feb 6, 2020 Dubai , United Arab Emirates More info and meet us there
AISF Pre-Meeting & AISF Annual Meeting Feb 26, 2020 - Feb 28, 2020 Rome , Italy More info and meet us there
Fujirebio launches INNO-LiPA® CFTRiage, allowing easy and efficient detection of CFTR mutations Jan 9, 2020 Fujirebio Europe announces the availability of its new INNO-LiPA CFTRiage approach for the detection of cystic fibrosis (CF) mutations. The... Read more
Fujirebio Europe N.V. signs distribution agreement and extends its molecular product portfolio with the Atila Biosystems, Inc. product lines Nov 19, 2019 Fujirebio Europe N.V. announces to have signed a European, exclusive agreement with Atila Biosystems, Inc. for the distribution of the... Read more
INNO-LiPA® HPV Genotyping Extra II now CE marked for use on self-collected first-void urine samples Sep 16, 2019 Fujirebio Europe announced today that its genotyping assay for Human Papilloma Virus (HPV), INNO-LiPA HPV Genotyping Extra II received a CE... Read more
Fujirebio launches the automated Lumipulse® G AMH assay for accurate assessment of ovarian reserve Apr 26, 2019 Fujirebio Europe announces the release of the Lumipulse G AMH assay for automated quantitative measurement of anti-Müllerian hormone in... Read more
Fujirebio expands its INNO-LiPA® CFTR assay portfolio with the launch of INNO-LiPA CFTR Extra Mar 18, 2019 Fujirebio Europe announces the release of the new INNO-LiPA® CFTR Extra assay for the detection of 18 new disease-causing cystic fibrosis... Read more
Fujirebio Europe announces the availability of the Lumipulse® G pTau 181 and β-Amyloid 1-40 assays extending its offer of fully automated assays as an aid in the early diagnosis of Alzheimer’s disease Nov 27, 2018 Fujirebio Europe today announced the availability of the Lumipulse G pTau 181 and β-Amyloid 1-40 assays for its fully automated LUMIPULSE G... Read more
